Portfolio
Quintiles Transnational
| Investment type | Growth Capital |
|---|---|
| Region | North America |
| Status | Current investment |
Nature of Business
Quintiles is a leading global provider of fully integrated bio and pharmaceutical outsourced services. It offers clinical and commercial drug development, consulting and capital solutions to its pharmaceutical and biotechnology customers.
Quintiles helps deliver new drugs and cures for the world’s most challenging diseases. Its 25,000+ employees across the globe have helped develop or commercialize each of the top 30 best-selling drugs on the market today.
Investment Overview
We made a significant investment in the recapitalization of Quintiles in January 2008, investing alongside Bain Capital, TPG and Quintiles CEO Dennis Gillings. Quintiles chose to partner with us due to our strong track-record in the healthcare sector and deep international network.
To assist in Quintiles’ continued growth, we have tapped into our extensive global healthcare network, which includes longstanding relationships with major pharmaceutical and biotech firms. As a result, we have introduced Quintiles to prospective healthcare customers across Europe and the US.
We have introduced a member of our Business Leaders Network as head of the recently formed EMEA Advisory Board, supported the Company’s plans to further expand into Asia, assisted with the spin-off of the non-core NovaQuest entity and helped strengthen key positions within the management team.